STOCK TITAN

Alan Waxman and TSSP Sub‑Fund HoldCo report stakes in CARIS Life Sciences (NASDAQ: CAI)

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

CARIS LIFE SCIENCES, INC. Schedule 13G/A (Amendment No. 2) discloses joint reporting by TSSP Sub-Fund HoldCo, LLC and Alan Waxman regarding beneficial ownership of Common Stock. As of March 31, 2026, the filing bases percentages on 282,579,919 shares outstanding as of February 26, 2026.

The cover data show Sub-Fund HoldCo with 13,666,128 shares (listed shared voting and dispositive power) representing 4.8% and Alan Waxman with 14,385,399 shares (listed shared voting and dispositive power) representing 5.1%. The filing describes layers of entity ownership and management relationships and includes joint filing and authorization exhibits.

Positive

  • None.

Negative

  • None.

Insights

Joint disclosure clarifies ownership and control lines across related entities.

The filing attributes shared voting and dispositive power to reported entities, listing specific share counts and a February 26, 2026 outstanding-share base of 282,579,919. It traces ownership through multiple LLCs and identifies management links between Sub-Fund HoldCo and Mr. Waxman.

Key dependencies include the holding structures named (Barnett Equity Holdings entities, TOP III Barnett Investments, Sixth Street affiliates) and the joint filing agreement. Subsequent filings could update percentages if holdings or the outstanding share count change.

Disclosure uses a standard disclaimer of beneficial ownership and attaches authorization exhibits.

The report expressly disclaims beneficial ownership of securities held directly by several named entities and attaches an Agreement of Joint Filing and an Authorization and Designation Letter. It ties percentage calculations to the issuer's Form 10-K share count disclosed on February 26, 2026.

Material filing qualifiers include the formal disclaimers and the joint-filing mechanism; cash-flow treatment and transaction intent are not part of this disclosure.

Shares outstanding (basis) 282,579,919 shares as of February 26, 2026
TSSP Sub-Fund HoldCo holdings 13,666,128 shares reported shared voting/dispositive power; coversheet shows <b>4.8%</b>
Alan Waxman holdings 14,385,399 shares reported shared voting/dispositive power; coversheet shows <b>5.1%</b>
Barnett Equity Holdings direct holdings 3,354,972 shares held directly by Barnett Equity Holdings, LLC (as stated in Item 4)
Sixth Street Specialty Lending Inc. direct holdings 719,271 shares held directly by Sixth Street Specialty Lending Inc. (as stated in Item 4)
Barnett Equity Holdings II direct holdings 5,960,051 shares held directly by Barnett Equity Holdings II, LLC (as stated in Item 4)
Agreement of Joint Filing regulatory
"Agreement of Joint Filing incorporated by reference herein"
beneficial ownership regulatory
"each Reporting Person disclaims beneficial ownership of the securities held directly"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared dispositive power financial
"Shared Dispositive Power 13,666,128.00 (cover page data)"
Authorization and Designation Letter regulatory
"Authorization and Designation Letter, dated December 31, 2024"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What ownership stake does TSSP Sub-Fund HoldCo report in CAI?

TSSP Sub-Fund HoldCo reports 13,666,128 shares, representing 4.8% of common stock. This percentage is calculated using 282,579,919 shares outstanding as of February 26, 2026 as stated in the filing.

What stake does Alan Waxman report in CARIS Life Sciences (CAI)?

Alan Waxman reports 14,385,399 shares, representing 5.1% of common stock. The filing attributes shared voting and dispositive power to the amounts shown on each cover page.

Which date is used to calculate the ownership percentages in this filing?

Percentages are calculated using 282,579,919 shares outstanding as of February 26, 2026, as disclosed in the issuer's Annual Report on Form 10-K referenced in the filing.

Do the Reporting Persons claim direct beneficial ownership of all listed shares?

No. Each Reporting Person disclaims beneficial ownership of shares held directly by named entities (Barnett Equity Holdings, Sixth Street Specialty Lending Inc., TOP III Barnett Investments, Barnett Equity Holdings II, TAO Barnett Investments).

What exhibits accompany this Amendment No. 2 to the Schedule 13G/A?

The filing references Exhibit 1 (Agreement of Joint Filing) and Exhibit 2 (Authorization and Designation Letter dated December 31, 2024), both previously filed and incorporated by reference.





142152107

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



TSSP Sub-Fund HoldCo, LLC
Signature:/s/ Joshua Peck
Name/Title:Joshua Peck, Vice President
Date:05/12/2026
Alan Waxman
Signature:/s/ Joshua Peck
Name/Title:Joshua Peck, on behalf of Alan Waxman (*)
Date:05/12/2026

Comments accompanying signature: Joshua Peck is signing on behalf of Mr. Waxman pursuant to an authorization and designation letter dated December 31, 2024.
Exhibit Information

Exhibit 1 - Agreement of Joint Filing (previously filed) Exhibit 2 - Authorization and Designation Letter, dated December 31, 2024, by Alan Waxman (previously filed)